DESVELITA - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 15,345 | 13,720 | 12,342 | 13,918 | 16,836 | 14,625 | 10,290 | 11,950 |
| Profit before tax | 388 | 308 | -471 | 179 | 178 | 590 | -996 | -465 |
| Net profit | 363 | 291 | -471 | 170 | 169 | 560 | -996 | -465 |
| Equity | 2,624 | 2,915 | 2,444 | 2,614 | 2,782 | 3,342 | 2,346 | 1,881 |
| Liabilities | 1,281 | 1,396 | 1,474 | 1,719 | 1,798 | 1,496 | 1,528 | 1,837 |
| Non-current assets | 162 | 82 | 352 | 239 | 146 | 54 | 0 | 0 |
| Current assets | 3,678 | 4,215 | 3,554 | 4,094 | 4,427 | 4,777 | 3,867 | 3,711 |
| Total assets | 3,840 | 4,297 | 3,906 | 4,333 | 4,573 | 4,831 | 3,867 | 3,711 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 85 | 82 | 48 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -10.8% | -10.6% | -10.0% | +12.8% | +21.0% | -13.1% | -29.6% | +16.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 9.5% | 6.8% | -12.1% | 3.9% | 3.7% | 11.6% | -25.8% | -12.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 13.8% | 10.0% | -19.3% | 6.5% | 6.1% | 16.8% | -42.5% | -24.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 2.4% | 2.1% | -3.8% | 1.2% | 1.0% | 3.8% | -9.7% | -3.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 2.5% | 2.2% | -3.8% | 1.3% | 1.1% | 4.0% | -9.7% | -3.9% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.5 | 0.5 | 0.6 | 0.7 | 0.6 | 0.4 | 0.7 | 1.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 5,115 | 4,573 | 4,114 | 6,959 | 8,418 | 7,020 | 5,145 | 5,975 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
DESVELITA - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-07-19 | 2026-07-26 | 295.87 |
| 2026-07-16 | 2026-07-17 | 295.87 |
| 2025-09-07 | 2025-09-11 | 0.27 |
| 2025-08-31 | 2025-09-03 | 0.27 |
| 2025-08-19 | 2025-08-29 | 0.27 |
| 2025-07-24 | 2025-08-13 | 0.27 |
| 2025-05-16 | 2025-05-18 | 248.44 |
DESVELITA - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
DESVELITA, UAB, company code 110855454, is a Private Limited Liability Company operating in medical specialists activities. In 2025, revenue increased to €11.9K, up 16.1% year on year from €10.3K in 2024, but it remained below the €14.6K recorded in 2023, leaving a two-year decline of 18.3%. Profitability stayed weak. The company reported a net loss of €465 in 2025, an improvement from the €996 loss in 2024, while 2023 still showed a small net profit of €560. The 2025 profit margin was -3.9%, compared with -9.7% in 2024 and 3.8% in 2023. The balance sheet remained small: total assets were €3.7K, equity €1.9K and liabilities €1.8K at year-end 2025. The equity ratio stood at 50.7% and debt-to-equity at 0.98, indicating a balanced but modest capital structure. Asset turnover was 3.22x. Revenue per employee was €6.0K and profit per employee was -€232.